Table 3. Comparing Site-Level ANC-RT with and without Continuation from ANC-UAT Sites.
Quantity | “True” Value | ANC-RT Data Scenario | Mean Difference | MAE | ||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Years of RT Data | Years of RT Data | |||||||
| ||||||||
1 | 3 | 5 | 1 | 3 | 5 | |||
Prevalence in 2011 (ρ2011) | 6.615% | 50 Resampled | −0.150% | −0.121% | 0.099% | 0.465% | 0.442% | 0.425% |
|
||||||||
50 with Continuity | −0.167% | −0.106% | 0.112% | 0.480% | 0.460% | 0.421% | ||
| ||||||||
Prevalence Change 2010–2011 (ρ2011–ρ2010) | −0.193% | 50 Resampled | 0.019% | 0.019% | 0.010% | 0.023% | 0.023% | 0.017% |
|
||||||||
50 with Continuity | 0.020% | 0.018% | 0.009% | 0.024% | 0.022% | 0.017% | ||
| ||||||||
Prevalence in 2016 (ρ2016) | 5.738% | 50 Resampled | −0.093% | −0.073% | 0.110% | 0.391% | 0.371% | 0.365% |
|
||||||||
50 with Continuity | −0.107% | −0.059% | 0.118% | 0.401% | 0.388% | 0.359% | ||
| ||||||||
Prevalence Change 2015–2016 (ρ2016–ρ2015) | −0.179% | 50 Resampled | 0.009% | 0.007% | 0.001% | 0.015% | 0.015% | 0.013% |
|
||||||||
50 with Continuity | 0.010% | 0.007% | 0.000% | 0.016% | 0.015% | 0.013% | ||
| ||||||||
Calibration btw UAT and RT (βRT) | −0.1000 | 50 Resampled | 0.0438 | 0.0352 | 0.0281 | 0.0602 | 0.0539 | 0.0494 |
|
||||||||
50 with Continuity | −0.0098 | −0.0191 | −0.0211 | 0.0331 | 0.0262 | 0.0276 | ||
| ||||||||
Calibration btw UAT and pregnant women (αUAT) | 0.2402 | 50 Resampled | −0.0273 | −0.0229 | −0.0378 | 0.0466 | 0.0467 | 0.0533 |
|
||||||||
50 with Continuity | 0.0177 | 0.0115 | 0.0118 | 0.0536 | 0.0480 | 0.0597 | ||
| ||||||||
Shared Non-Sampling Variance of UAT and RT ( ) | 0.01301 | 50 Resampled | 0.00125 | −0.00028 | −0.00008 | 0.00426 | 0.00157 | 0.00119 |
|
||||||||
50 with Continuity | 0.00072 | −0.00042 | −0.00007 | 0.00322 | 0.00181 | 0.00118 |